sur Athos KG
Strüngmann Award 2026 Finalists Unveiled
Athos KG has announced the finalists for the 2026 Strüngmann Award, which honors life sciences entrepreneurs in the DACH region. This year, Dr. Stefano Portolano, Prof. Dr. med. Wieland Sommer, and Dr. Jonathan Talbot stand out as leading contenders. The award, accompanied by a EUR 100,000 prize, will be presented on September 15, 2026.
Dr. Stefano Portolano's company, Azafaros, focuses on therapies for rare metabolic disorders, including the promising nizubaglustat. Prof. Dr. med. Wieland Sommer's firm, Jacobian, has significantly advanced radiological reporting through its automated platform. Dr. Jonathan Talbot has led Mosanna and Melodia Therapeutics, pushing forward new treatments for sleep apnea and inflammatory diseases.
The finalists will present their projects to a jury of experts to decide the ultimate winner, showcasing how they have turned innovative scientific concepts into applicable products that benefit patients globally.
R. P.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Athos KG